M. F. Waters
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
M. F. Waters has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
C. M. DeGiorgio
Department of Neurology, UCLA School of Medicine, Los Angeles, CA, USA
1 shared publicationD. C. Shields
From the Department of Neurology (Drs. Waters, Baloh, and Jen) and Divisions of Neurosurgery (Drs. Shields and Martin) and Head and Neck (Dr. Baloh), Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, CA
1 shared publicationG. A. Kang
Department of Neurology, UCLA School of Medicine, Los Angeles, CA, USA
1 shared publicationJ. C. Jen
From the Department of Neurology (Drs. Waters, Baloh, and Jen) and Divisions of Neurosurgery (Drs. Shields and Martin) and Head and Neck (Dr. Baloh), Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, CA
1 shared publicationJ. C. Mazziotta
Department of Neurology, UCLA School of Medicine, Los Angeles, CA, USA
1 shared publication- Neil A. Martin
Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles; and
1 shared publication
Latest Publications
- 1 October 2005
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 112 (4) , 270-272
Nitrous oxide inhalation as a cause of cervical myelopathy
Current evidence suggests that the incidence of recreational nitrous oxide inhalation is on the rise. Due to the possibility of clinically significant myelopathy, as well as potential response to treatment, it is important to consider this diagnosis when appropriate. We present a case of acquired ataxia and myelopathy due to nitrous oxide abuse and discuss diagnosis, pathophysiology, and response to treatment.
- 1 October 2005
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 112 (4) , 270-272
Nitrous oxide inhalation as a cause of cervical myelopathy
Current evidence suggests that the incidence of recreational nitrous oxide inhalation is on the rise. Due to the possibility of clinically significant myelopathy, as well as potential response to treatment, it is important to consider this diagnosis when appropriate. We present a case of acquired ataxia and myelopathy due to nitrous oxide abuse and discuss diagnosis, pathophysiology, and response to treatment.
- 27 September 2005
- Published by Wolters Kluwer Health in Neurology
- Vol. 65 (6) , 966-967
Novel CCM1 mutation in a patient with paraparesis and thoracic cord cavernous malformation
- 27 September 2005
- Published by Wolters Kluwer Health in Neurology
- Vol. 65 (6) , 966-967
Novel CCM1 mutation in a patient with paraparesis and thoracic cord cavernous malformation
- 1 September 2005
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 112 (3) , 192-193
Favorable longitudinal outcome in a patient with Parry-Romberg syndrome
- 1 September 2005
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 112 (3) , 192-193
Favorable longitudinal outcome in a patient with Parry-Romberg syndrome